Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Seroquel in Bipolar Depression Versus SSRI

ClinicalTrials.gov ID: NCT00119652

Public ClinicalTrials.gov record NCT00119652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 9:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicentre, Double-blind, Randomised, Parallel Group, Placebo Controlled, Phase 3 Study of the Efficacy & Safety of Quetiapine Fumarate & Paroxetine as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks & Quetiapine in Continuation (Abbreviated)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether quetiapine is effective and safe in the acute treatment of bipolar depression and whether the effect is maintained when treatment is continued.

Study identification

NCT ID
NCT00119652
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
676 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2005 (Type not available)
Primary completion
Not listed
Completion
May 2007 (Actual)
Last update posted
Jan 4, 2013

2005 – 2007

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
28
Facility City State ZIP Site status
Research Site Phoenix Arizona — —
Research Site Little Rock Arkansas — —
Research Site National City California — —
Research Site San Clemente California — —
Research Site San Diego California — —
Research Site Maitland Florida — —
Research Site Winter Park Florida — —
Research Site Atlanta Georgia — —
Research Site Smyrna Georgia — —
Research Site Northfield Illinois — —
Research Site Oak Brook Illinois — —
Research Site New Orleans Louisiana — —
Research Site Shreveport Louisiana — —
Research Site Glen Burnie Maryland — —
Research Site St Louis Missouri — —
Research Site Clementon New Jersey — —
Research Site New York New York — —
Research Site Raleigh North Carolina — —
Research Site Cincinnati Ohio — —
Research Site Dayton Ohio — —
Research Site Oklahoma City Oklahoma — —
Research Site Philadelphia Pennsylvania — —
Research Site Austin Texas — —
Research Site Dallas Texas — —
Research Site Irving Texas — —
Research Site Richmond Virginia — —
Research Site Bellevue Washington — —
Research Site Kirkland Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00119652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 4, 2013 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00119652 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →